Article
Grading HER2 at the nanoscale in clinical tissue
2026-01-14
Abstract excerpt
To guide diagnosis and treatment, breast cancer biopsies are assessed for HER2 status and assigned one of four grades (0-3+). While current practices are sufficient for detection of HER2 overexpression (3+), there is a need for more sensitive methods capable of characterising lower HER2 expression in patients who may still benefit from HER2-targeted therapies. Super-resolution fluorescence microscopy techniques, s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 705acb92-7071-5429-b7d4-532b04d0bc48
- DOI
- 10.64898/2026.01.14.695095
